Author Correction: OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
Nature, Published online: 13 July 2026; doi:10.1038/s41586-026-10855-3
Author Correction: OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumoursNature, Published online: 13 July 2026; doi:10.1038/s41586-026-10855-3
Author Correction: OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumoursNature, Published online: 03 June 2026; doi:10.1038/s41586-026-10612-6
Longitudinal transcriptomic, chromatin and genomic analyses of the two types of IDH-mutant glioma reveal in detail how disease progression is influenced by interdependent genetic, epigenetic and microenvironmental factors.